Literature DB >> 18221618

Surgical methods to reverse left ventricular remodeling.

Michele De Bonis1, Ottavio Alfieri.   

Abstract

Heart transplantation remains the gold standard treatment for "end-stage" dilated cardiomyopathy. However, its epidemiologic impact on the heart failure problem continues to be small due to limited donor organ availability and contraindications. Therefore, several "conventional" surgical procedures have been developed to reverse the vicious cycle of ventricular remodeling that accompanies systolic heart failure and to improve symptoms and survival of the patients. This review discusses indications, results, and limitations of the most common surgical methods currently used to arrest or reverse cardiac remodeling.

Entities:  

Mesh:

Year:  2007        PMID: 18221618     DOI: 10.1007/s11897-007-0015-4

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  46 in total

1.  The role of coronary revascularization in the treatment of ischemic cardiomyopathy.

Authors:  Bruce W Lytle
Journal:  Ann Thorac Surg       Date:  2003-06       Impact factor: 4.330

2.  Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis.

Authors:  Jeroen J Bax; Arend F L Schinkel; Eric Boersma; Abdou Elhendy; Vittoria Rizzello; Alexander Maat; Jos R T C Roelandt; Ernst E van der Wall; Don Poldermans
Journal:  Circulation       Date:  2004-09-14       Impact factor: 29.690

3.  Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy: role of the "edge-to-edge" technique.

Authors:  Michele De Bonis; Elisabetta Lapenna; Giovanni La Canna; Eleonora Ficarra; Marco Pagliaro; Lucia Torracca; Francesco Maisano; Ottavio Alfieri
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

4.  Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes.

Authors:  Marc A Simon; Robert L Kormos; Srinivas Murali; Pradeep Nair; Michael Heffernan; John Gorcsan; Stephen Winowich; Dennis M McNamara
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

5.  Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction.

Authors:  Khaldoun G Tarakji; Richard Brunken; Patrick M McCarthy; M Obadah Al-Chekakie; Ahmed Abdel-Latif; Claire E Pothier; Eugene H Blackstone; Michael S Lauer
Journal:  Circulation       Date:  2006-01-03       Impact factor: 29.690

6.  Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy.

Authors:  A Yamaguchi; T Ino; H Adachi; S Murata; H Kamio; M Okada; J Tsuboi
Journal:  Ann Thorac Surg       Date:  1998-02       Impact factor: 4.330

7.  Clinical results with the Acorn cardiac restraint device with and without mitral valve surgery.

Authors:  Michael A Acker
Journal:  Semin Thorac Cardiovasc Surg       Date:  2005

8.  New surgical options for the failing heart.

Authors:  P M McCarthy
Journal:  J Heart Valve Dis       Date:  1999-09

9.  The beneficial effect of revascularization on jeopardized myocardium: reverse remodeling and improved long-term prognosis.

Authors:  Jacopo Dalle Mule; Jeroen J Bax; Bartolo Zingone; Felice Martinelli; Claudio Burelli; Anna Stefania; Liberata DiSipio; Giorgio Soravia
Journal:  Eur J Cardiothorac Surg       Date:  2002-09       Impact factor: 4.191

Review 10.  Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target.

Authors:  Judy Hung; Lampros Papakostas; Stephen A Tahta; Bruce G Hardy; Bruce A Bollen; Carlos M Duran; Robert A Levine
Journal:  Circulation       Date:  2004-09-14       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.